Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Frontline”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02613208
What this trial is testing

Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 111
Testing effectiveness (Phase 2)Ended earlyNCT03733691
What this trial is testing

Ph 2 Maintenance Trial: Ixazomib vs Ixazomib-Lenalidomide for MM Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
Oncotherapeutics 19
Testing effectiveness (Phase 2)Looking for participantsNCT06495515
What this trial is testing

Dalpiciclib Plus Toremifene for First-line Advanced HR Positive and HER2 Negative Breast Cancer

Who this might be right for
CANCERBRAEST CANCERLate Frontline
Tianjin Medical University Cancer Institute and Hospital 36
Post-approval studies (Phase 4)Active Not RecruitingNCT06121401
What this trial is testing

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Who this might be right for
Carcinoma, Ovarian Epithelial
Mario Negri Institute for Pharmacological Research 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT03407144
What this trial is testing

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 340
Not applicableStudy completedNCT04443075
What this trial is testing

Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress

Who this might be right for
Stress Disorders, Post-Traumatic
First Affiliated Hospital Xi'an Jiaotong University 180
Not applicableStudy completedNCT03576157
What this trial is testing

Kilkari Impact Evaluation

Who this might be right for
Breast FeedingFamily PlanningEssential Newborn Care+1 more
Johns Hopkins Bloomberg School of Public Health 5,095
Not applicableUnknownNCT05816304
What this trial is testing

Effectiveness of Digital Cognitive Behavioral Therapy for Insomnia in Frontline Health Care Workers (The HCW-CBTi Study)

Who this might be right for
InsomniaPost Traumatic Stress DisorderAnxiety Disorders+1 more
University Health Network, Toronto 366
Not applicableStudy completedNCT06106087
What this trial is testing

Supporting Healthcare Improvement Through Facilitation & Training

Who this might be right for
Frontline Staff Working Within Personal Care Home Facilities
University of Manitoba 11
Testing effectiveness (Phase 2)Looking for participantsNCT06930352
What this trial is testing

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

Who this might be right for
Acute Myeloid Leukemia
Uma Borate 70
Early research (Phase 1)Ended earlyNCT04204941
What this trial is testing

Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma

Who this might be right for
Advanced Soft-tissue SarcomaAdvanced Epithelioid Sarcoma
Epizyme, Inc. 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06474481
What this trial is testing

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

Who this might be right for
FL
Tianjin Medical University Cancer Institute and Hospital 30
Not applicableLooking for participantsNCT06151002
What this trial is testing

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

Who this might be right for
Parkinson Disease
University College London Hospitals 4,800
Not applicableStudy completedNCT05577351
What this trial is testing

Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Patients With Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
RapidPulse, Inc 5
Testing effectiveness (Phase 2)UnknownNCT03624270
What this trial is testing

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

Who this might be right for
Acute Promyelocytic Leukemia
The University of Hong Kong 60
Large-scale testing (Phase 3)Study completedNCT05163496
What this trial is testing

Frontline Clinician Psilocybin Study

Who this might be right for
Burnout, CaregiverBurnout, ProfessionalCOVID-19+3 more
University of Washington 30
Testing effectiveness (Phase 2)Study completedNCT03382561
What this trial is testing

Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaRecurrent Lung Small Cell Carcinoma
National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT00254410
What this trial is testing

FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Ended earlyNCT05616624
What this trial is testing

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

Who this might be right for
Non Small Cell Lung CancerNon-small Cell Lung CancerSmall-cell Lung Cancer+1 more
Washington University School of Medicine 31
Not applicableActive Not RecruitingNCT06070961
What this trial is testing

Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 56
Next Page